Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Large Genetic Screen Identifies Eight New Variants Linked to Skin Cancer Risk

By LabMedica International staff writers
Posted on 11 Mar 2020
A large genome-wide association study (GWAS) identified eight new gene loci linked to the risk of developing cutaneous squamous cell carcinoma.

Cutaneous squamous cell carcinoma (SCC) is one of the most common cancers in the United States. More...
In contrast to melanoma, SCC usually responds to treatment and rarely spreads to other parts of the body.

Previous genome-wide association studies have identified 14 single nucleotide polymorphisms (SNPs) associated with cutaneous SCC. Investigators at Indiana University (Indianapolis, USA) have expanded this knowledge by performing the largest cutaneous SCC meta-analysis to date, incorporating six international cohorts and totaling 19,149 SCC cases and 680,049 controls.

Results of this study revealed eight novel loci associated with SCC and confirmed the 14 previously associated loci. The investigators also performed fine mapping of the causal gene variants. They found that the novel SNPs occurred within skin-specific regulatory elements and implicated loci involved in cancer development, immune regulation, and keratinocyte differentiation.

Results of the current study have increased the known SCC-related loci to 22. However, these loci account for only 8.5% of the heritable risk for squamous cell skin cancer.

“This is the largest genetic-associated study for squamous cell carcinoma of the skin,” said senior author Dr. Jiali Han, professor of epidemiology at Indiana University. “Our multidisciplinary research sheds light on new biology and the etiology of squamous cell carcinoma, confirming some important genes and also identifying genes involved in this particular cancer development. We can certainly say there is some genetic overlap between squamous cell carcinoma, basal cell carcinoma, and melanoma - the three major types of skin cancer - but we also found some genes are specific for squamous cell carcinoma.”

The SCC genome-wide association study was published in the February 10, 2020, online edition of the journal Nature Communications.

Related Links:
Indiana University


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.